This year’s most-read stories covered uncertainty at the USPTO, a potential boycott of a major international IP conference, rankings releases, and a contempt of court proceeding ...

The parties have agreed on a court-guided settlement covering Pantech’s entire SEP portfolio, marking a global first ...

The introduction of Canada’s patent term adjustment has left practitioners sceptical about its value, with high fees and limited eligibility meaning SMEs could lose out ...

USPTO director John Squires is recognised for his policy changes to inter partes review and post-grant review proceedings. Although Squires has only recently been named director, he has made ...

Hoglund, who announced yesterday, December 15, that he is to leave Via at the end of 2025, is set to reveal his new venture in the new year.

Varuni Paranavitane of Finnegan and IP counsel Lisa Ribes compare and contrast two recent AI copyright decisions from Germany and the UK Recent Court decisions in the UK and Germany highlight ...

The winner of a high-profile bidding war for Warner Bros Discovery may gain a strategic advantage far greater than mere subscriber growth - IP licensing leverage Warner Bros Discovery’s potential ...

In this episode, sponsored by Zacco, we delve into Online IP Protection and how the concept of protecting brands online is evolving. Many of you will have heard of Online Brand Protection, a service ...

Viji Krishnan of Corsearch unpicks the results of a survey that reveals almost 80% of trademark practitioners believe in a hybrid AI model for trademark clearance and searches Trademark portfolios and ...

David Ives, Laura Houston, and Richard Barker of Slaughter and May examine the UK High Court’s ruling and assess its implications for AI developers, rights holders, and future appeals On November 4 ...

Welcome to the latest instalment of Managing IP’s ‘Five minutes with’ series, where we learn more about intellectual property practitioners, or those working in the IP profession, on a personal and ...

Koen Bijvank of Brinkhof and Johannes Heselberger of Bardehle Pagenberg discuss the Amgen v Sanofi case and why it will be cited frequently Amgen successfully defended its European patent (EP ...